Trial Profile
Atomoxetine; comparison of levels in oral fluids and plasma in paediatric patients with attention-deficit-hyperactivity disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- 29 Oct 2015 Results presented at the 12th Congress of the European Association for Clinical Pharmacology and Therapeutics
- 29 Oct 2015 New trial record